Hope as even most aggressive prostate cancers respond to drug

MEN who expect to die from prostate cancer have been offered new hope by drug researchers.

A preliminary trial has shown that a new drug, abiraterone, can reverse even the most aggressive, resistant and deadly cancers. This could be the biggest advance in treating the disease in 60 years.

Latest data from the National Cancer Registry of Ireland revealed 2,406 new cases of prostate cancer were diagnosed in 2005, with 88% of these over 50 years of age. It estimates there will be a 275% increase in sufferers by 2020.